Breaking News Instant updates and real-time market news.

VLKAY

Volkswagen

$31.19

0.25 (0.81%)

, UTX

United Technologies

$117.92

-1.8 (-1.50%)

20:02
09/04/17
09/04
20:02
09/04/17
20:02

On The Fly: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. United Technologies (UTX) and Rockwell Collins (COL) have announced that they have reached a definitive agreement under which United Technologies will acquire Rockwell Collins for $140 per share, in cash and stock. The transaction is projected to close by Q3 of 2018, subject to approval by Rockwell Collins' share owners, as well as other customary closing conditions, including the receipt of required regulatory approvals. The purchase price implies a total equity value of $23B and a total transaction value of $30B, including Rockwell Collins' net debt. 2. Volkswagen (VLKAY) has put the $1.8B sale of Ducati motorcycles on hold after resistance from German trade unions and internal rifts on strategy, according to a report by Reuters, citing sources familiar with the matter. Ducati is wholly controlled by Volkswagen's luxury brand Audi, which is at odds with the parent over strategy, and a decision to sell the 91-year old business, the publication noted. 3. Hurricane Harvey may be one of the costliest disasters for property and casualty insurers, but it probably will not change weak commercial and reinsurance pricing, or will it be enough to dent the industry's huge capital base, Andrew Bary wrote in this week's edition of Barron's. The bulk of the industry's losses should come from commercial policies, while losses on homeowner's insurance are expected to be moderate, since policies exclude flood coverage, he noted. Bary argued that Chubb (CB) looks like one of the better industry plays, with double the market value of Allstate (ALL) or Progressive (PGR), and with probably more growth opportunity than the largely domestic Travelers (TRV). 4. In the worst Labor Day in 20 years, Lionsgate' (LGF.A) action comedy "Hitman's Bodyguard" benefited from lack of competition, grossing $10.5M from 3,370 theaters for the three days and $13.4M for the four. The movie's domestic total through Monday is an estimated $58.1M. 5. Nathan's Famous (NATH), Honda (HMC), Sony (SNE), Wal-Mart (WMT), BlackRock (BLK), New Relic (NEWR), Ansys (ANSS), and Flex (FLEX) saw positive mentions in Barron's, while Papa John's (PZZA), DaVita (DVA) and American Renal (ARA) were mentioned cautiously.

VLKAY

Volkswagen

$31.19

0.25 (0.81%)

UTX

United Technologies

$117.92

-1.8 (-1.50%)

COL

Rockwell Collins

$130.61

-0.44 (-0.34%)

CB

Chubb

$140.49

-0.93 (-0.66%)

ALL

Allstate

$89.78

-0.72 (-0.80%)

PGR

Progressive

$45.66

-0.82 (-1.76%)

TRV

Travelers

$119.90

-1.28 (-1.06%)

LGF.A

Lionsgate

$30.35

0.62 (2.09%)

NATH

Nathan's Famous

$56.95

-1.6 (-2.73%)

HMC

Honda

$28.21

0.11 (0.39%)

SNE

Sony

$39.72

0.09 (0.23%)

WMT

Wal-Mart

$78.37

0.3 (0.38%)

BLK

BlackRock

$421.78

2.77 (0.66%)

NEWR

New Relic

$47.98

0.08 (0.17%)

ANSS

ANSYS

$128.11

-0.71 (-0.55%)

FLEX

Flex

$16.54

0.27 (1.66%)

PZZA

Papa John's

$74.42

-0.37 (-0.49%)

DVA

DaVita

$57.88

-0.68 (-1.16%)

ARA

American Renal Associates

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 07

    Sep

  • 08

    Sep

  • 09

    Sep

  • 11

    Sep

  • 11

    Sep

  • 11

    Sep

  • 12

    Sep

  • 13

    Sep

  • 13

    Sep

  • 27

    Sep

  • 29

    Sep

  • 16

    Nov

  • 21

    Nov

  • 20

    Feb

VLKAY Volkswagen
$31.19

0.25 (0.81%)

08/07/17
JEFF
08/07/17
DOWNGRADE
JEFF
Hold
Volkswagen downgraded to Hold from Buy at Jefferies
Jefferies analyst Philippe Houchois downgraded Volkswagen to Hold and lowered his price target for the shares to EUR 145 from EUR 160.
04/18/17
JEFF
04/18/17
UPGRADE
JEFF
Buy
Volkswagen upgraded to Buy from Underperform at Jefferies
Jefferies analyst Philippe Jean Houchois double upgraded Volkswagen to Buy from Underperform and raised his price target for the shares to EUR 160 from EUR 110.
02/13/17
JEFF
02/13/17
NO CHANGE
Target $52
JEFF
Buy
Jefferies says Mobileye agreement not unexpected, but important
Mobileye's (MBLY) agreement with Volkswagen (VLKAY) is not expected given the previously disclosed memorandum of understanding, but it is important nonetheless, Jefferies analyst David Kelley tells investors in a research note. The deal substantiates Mobileye's "strong" early positioning" in the integral segment of the "rapidly developing" autonomous vehicle sector, the analyst contends. He keeps a Buy rating on the shares with a $52 price target.
02/13/17
RAJA
02/13/17
NO CHANGE
RAJA
Outperform
Mobileye deal with VW has longer-term value, says Raymond James
Raymond James analyst Tavis McCourt noted that Volkswagen's (VLKAY) partnership with Mobileye (MBLY) to use REM technology in its autonomous vehicles was announced back in early 2016, but only finalized today. While the pact has "no meaningful influence" near-term, it does have longer-term financial and strategic value for Mobileye, said McCourt, who keeps an Outperform rating on the shares.
UTX United Technologies
$117.92

-1.8 (-1.50%)

08/07/17
RBCM
08/07/17
NO CHANGE
RBCM
Rockwell Collins could be acquired for $145 per share, says RBC Capital
After Reuters and Bloomberg reported that United Technologies (UTX) had made an unconfirmed bid to buy Rockwell Collins (COL), RBC Capital analyst Matthew McConnell estimates that Rockwell Collins could be acquired for $145 per share. The analyst says that the deal would strengthen United Technologies and has "ample strategic rationale," although he notes that airplane makers have expressed opposition to similar deals in the past. He adds that the deal "would move" United Technologies "up the technology curve" and enable it to enter the avionics business which he says has high barriers of entry. McConnell thinks that there is a 50% chance of a deal taking place and raised his price target on Rockwell Collins to $133 from $120. He keeps a Sector Perform rating on Rockwell Collins.
08/07/17
JPMS
08/07/17
NO CHANGE
JPMS
Neutral
JPMorgan views potential Rockwell deal as mixed for United Technologies
JPMorgan analyst C. Stephen Tusa says that at face value, he would view an acquisition of Rockwell Collins (COL) as a "mixed event" for United Technologies (UTX). Benefits include a solid strategic rationale that plays into the broader aerospace sector narrative and some earnings accretion, Tusa tells investors in a research note after Bloomberg reported Friday that United Technologies is mulling the deal. However, the potential size of the acquisitions dilutes the positives somewhat and makes achieving targeted returns a challenge, Tusa contends. He adds that a stock issuance may be required for United Technologies. The analyst has a Neutral rating on the shares.
08/07/17
08/07/17
NO CHANGE

Wells says United Technologies unlikely to buy Rockwell Collins soon
After Bloomberg reported that United Technologies (UTX) is considering buying Rockwell Collins (COL), Wells Fargo calls the timing of its interest "surprising," partly because major airplane makers, including Boeing (BA), are considering moving into avionics and aftermarket as well. The firm thinks that this situation would increase the risk of an acquisition of Rockwell Collins for United Technologies. Wells is "skeptical" that such a deal is "imminent," but estimates that United would pay about $150 per share for Rockwell and says a 100% cash transaction would be 9% accretive for United. Wells keeps Outperform ratings on both stocks.
08/23/17
08/23/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Rockwell Collins (COL) upgraded to Buy from Hold at Vertical Research by analyst Robert Stoddard, as he believes there remains the possibility of the company being acquired. As detailed in colleague Jeff Sprague's related report United Technologies (UTX), the two analysts cannot rule out United Technologies making a bid for Rockwell Collins. They believe it could be more exotically structured as a Reverse Morris Trust, which would make a transaction more financially appealing to United Technologies shareholders, while preserving its credit rating, and providing Rockwell Collins shareholder with a decent premium. 2. JD.com (JD) upgraded to Buy from Hold at MKM Partners by analyst Rob Sanderson based on valuation and his belief that Chinese e-commerce is powerful enough to support "a strong number two," while the company's "position" is "sustainably differentiated." 3. IDEXX (IDXX) upgraded to Buy from Neutral at BofA/Merrill by analyst Derik De Bruin, who said new data supports 10% long-term organic revenue and 15%-20% earnings CAGRs through 2022 driven by higher diagnostic utilization by the installed base, new product ramps, and further innovation. The analyst said the pullback since the solid Q2 report provides a buying opportunity for this "top dog." 4. Intuit (INTU) upgraded to Equal-Weight from Underweight at First Analysis by analyst James Macdonald, who raised his price target to $128 from $102 following the "strong" quarter and better than expected 2018 guidance driven by Small Business growth. 5. G-III Apparel (GIII) upgraded to Overweight from Neutral at Piper Jaffray by analyst Erinn Murphy to reflect the recent pullback in shares and maintained a $27 price target. The analyst expects wholesale trends to "fuel upside" and believes the new DKNY product is checking well at retail. To see The Fly's full Street Research coverage, click here.
COL Rockwell Collins
$130.61

-0.44 (-0.34%)

08/22/17
VERT
08/22/17
UPGRADE
Target $143
VERT
Buy
Rockwell Collins upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Robert Stoddard upgraded Rockwell Collins (COL) to Buy with a $143 price target, as he believes there remains the possibility of the company being acquired. As detailed in colleague Jeff Sprague's related report United Technologies (UTX), the two analysts cannot rule out United Technologies making a bid for Rockwell Collins. They believe it could be more exotically structured as a Reverse Morris Trust, which would make a transaction more financially appealing to United Technologies shareholders, while preserving its credit rating, and providing Rockwell Collins shareholder with a decent premium.
CB Chubb
$140.49

-0.93 (-0.66%)

09/01/17
MSCO
09/01/17
NO CHANGE
MSCO
Harvey loss uncertainty to remain overhang on P&C stocks, says Morgan Stanley
Morgan Stanley analyst Kai Pan currently estimates $15B-$40B in total insured losses from Harvey, including $5B-$15B in National Flood Insurance Program, or NFIP, claims. P&C stocks the firm covers have declined 2.7% on average since August 23, noted Pan, who thinks the uncertainty of losses will remain a near-term overhang on the group. If the ultimate losses are contained within quarterly earnings, the stocks could rebound, added Pan. Stocks in the P&C insurance space include Allstate (ALL), Travelers (TRV), Progressive (PGR), Chubb (CB), AIG (AIG).
08/28/17
JPMS
08/28/17
NO CHANGE
JPMS
JPMorgan sees up to $20B of insured losses from Harvey
Harvey could result in $10B-$20B of industry insured losses making it one of the top 10 most costly hurricanes to hit the U.S., JPMorgan analyst Sarah DeWitt tells investors in a research note. The analyst lists Validus (VR), RenaissanceRe (RNR), Everest Re (RE), XL Group (XL), Arch Capital (ACGL), Travelers (TRV), Chubb (CB), Allstate (ALL) and Progressive (PGR) as the property casualty insurers with the most exposure to Texas hurricanes.
08/10/17
WELS
08/10/17
NO CHANGE
Target $164
WELS
Outperform
Chubb removed from Priority Stock List at Wells Fargo
Wells Fargo analyst Elyse Greenspan removed Chubb from her firm's Priority Stock List but keeps an Outperform rating on the shares with a $164 price target. The list now only includes Well's top pick in the non life insurance sector, the analyst adds.
04/26/17
RBCM
04/26/17
NO CHANGE
Target $153
RBCM
Outperform
Chubb price target raised to $153 from $140 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on Chubb to $153 from $140 and reiterates an Outperform rating on the insurer, which he continues to view as his favorite large-cap P&C insurer.
ALL Allstate
$89.78

-0.72 (-0.80%)

08/03/17
08/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Perform from Outperform at Oppenheimer with analyst Derek Archila saying he no longer sees a "clear path" for Teva to return to growth in a "timely manner" amid continued pricing pressure in U.S. generics. 2. Charter (CHTR) downgraded to Neutral from Buy at Guggenheim with analyst Michael Morris citing valuation and increased his price target to $400 from $370. 3. Allstate (ALL) downgraded to Hold from Buy at Deutsche Bank with analyst Joshua Shanker citing valuation. 4. Mattel (MAT) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser saying she left a recent management meeting with a more cautious outlook for the company's performance in the second half of 2017. 5. Lam Research (LRCX) downgraded to Neutral from Buy at Citi with analyst Atif Malik saying he's becoming more selective in the Semiconductor Capital Equipment space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/17
DBAB
08/03/17
DOWNGRADE
Target $96
DBAB
Hold
Allstate downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Joshua Shanker downgraded Allstate to Hold citing valuation. The analyst believes his Buy thesis "has run its course." He raised his price target for the shares to $96 from $90.
PGR Progressive
$45.66

-0.82 (-1.76%)

07/13/17
07/13/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying Snap shares offer a "compelling risk/reward opportunity." 2. Progressive (PGR) upgraded to Strong Buy from Outperform at Raymond James with analyst Gregory Peters saying he believes Progressive will continue to grow net premiums written at a double digit pace through 2017 and is well positioned to benefit from emerging smartphone technology to monitor and price for distracting driving over the next 24 months. 3. Agilent (A) upgraded to Outperform from Market Perform at Wells Fargo. 4. Hain Celestial (HAIN) upgraded to Buy from Hold at Maxim with analyst Anthony Vendetti saying that its fiscal 2018 guidance implies a turnaround in its business while the company's reporting of its prior financials without any major restatements has removed an accounting overhang. 5. Fastenal (FAST) upgraded to Strong Buy from Outperform at Raymond James analyst Sam Darkatsh saying he thinks yesterday's selloff in Fastenal shares is entirely related to MSC Industrial's (MSM) gross margin commentary and is unwarranted. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/17
RAJA
07/13/17
UPGRADE
RAJA
Strong Buy
Progressive upgraded on improving auto cycle profits at Raymond James
As previously reported, Raymond James upgraded Progressive to Strong Buy from Outperform and increased its price target to $52 from $45. Analyst Gregory Peters believes Progressive will continue to grow net premiums written at a double digit pace through 2017 and is well positioned to benefit from emerging smartphone technology to monitor and price for distracting driving over the next 24 months. He expects up to 15% of the personal auto business could begin to report up to 20% decline in risky driving habits over the next 18 months, resulting in improving underwriting margins.
TRV Travelers
$119.90

-1.28 (-1.06%)

06/19/17
06/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Costco (COST) downgraded to Hold from Buy at Deutsche Bank with analyst Paul Trussell saying positive pipeline catalysts have played out while competition is intensifying with Amazon.com (AMZN) and Wal-Mart (WMT) accelerating in-store and online efforts. The analyst lowered his price target for the shares to $172 from $187. 2. Kroger (KR) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Vincent Sinisi saying there is increased structural margin risk within the Food Retail sector following Amazon's (AMZN) acquisition of Whole Foods (WFM) and said stocks are now appropriately pricing in flat medium-term growth. 3. Wayfair (W) downgraded to Hold from Buy at Maxim with analyst Tom Forte saying he views the current share price as fully reflecting its revenue growth opportunity over the next three years and his expectation that the company can meet the top-end of its long-term adjusted EBITDA margin target of 8%-10%. 4. Travelers (TRV) downgraded to Neutral from Buy at BofA/Merrill with analyst Jay Cohen citing valuation. 5. TripAdvisor (TRIP) downgraded to Underperform from Neutral at Credit Suisse with analyst Paul Bieber citing raised expectations for TV ad spending in 2018 paired with uncertainty regarding the return on TV advertising investment given the crowded ad market for online travel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/17
ARGS
07/28/17
NO CHANGE
ARGS
Travelers weakness creates attractive entry point, says Argus
After Travelers reported lower than expected EPS, Argus analyst Jacob Kilstein notes that the company's Q2 revenue beat expectations. He expects the company's margins and ROIC to improve going forward and recommends buying the stock on weakness.
LGF.A Lionsgate
$30.35

0.62 (2.09%)

06/27/17
DBAB
06/27/17
INITIATION
Target $29
DBAB
Hold
Lionsgate initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. The analyst views consensus estimates as too high but sees potential upside through consolidation.
06/27/17
06/27/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. JPMorgan analyst Alex Yao resumed coverage of Alibaba (BABA) Group with an Overweight rating and $190 price target following a period of restriction. The rating is unchanged and the price target is raised from $140. 2. SunTrust analyst Terry Tillman initiated Salesforce (CRM) with a Buy and a $110 price target and views its as a core holding for large-cap investors. 3. Citi analyst Joel Beatty started Arena Pharmaceuticals (ARNA) with a Buy rating and $23 price target. 4. Deutsche Bank analyst Bryan Kraft started Lionsgate Class A (LGF.A) shares with a Hold rating and $29 price target. 5. Cantor Fitzgerald analyst Louise Chen assumed coverage of Amarin (AMRN) with an Overweight rating and $10 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/21/17
07/21/17
NO CHANGE

Lionsgate price target raised to $36 from $29 at Loop Capital
Loop Capital analyst David Miller said that while Lionsgate shares have grinded higher as the company "continues to do what it has always done very well," he also has confidence that it is well ahead of plan on Starz synergies and that it has potential from "second-window" sales of streaming rights and orders from OTT platforms. Miller raised his price target on Lionsgate B shares to $36 from $29 and keeps a Buy rating on the name.
08/30/17
08/30/17
NO CHANGE
Target $35

Overweight
Lionsgate shares remain attractive, says Piper Jaffray
After analyzing the company's film studio, Piper Jaffray analyst Stan Meyers says shares of Lionsgate remain attractive for a "fast growing studio" with expanding margins and solid free cash flow generation. The analyst remains upbeat on the company as Starz transitions into a growth story and it continues to deliver high quality TV content while "systematically assembling a de-risked, diversified film slate." Meyers' base case scenario points to a $35 valuation, which is his price target, $26 in the bear case and $40 in the bull case. He keeps an Overweight rating on Lionsgate.
NATH Nathan's Famous
$56.95

-1.6 (-2.73%)

HMC Honda
$28.21

0.11 (0.39%)

07/05/17
JPMS
07/05/17
DOWNGRADE
JPMS
Honda downgraded to Neutral from Overweight at JPMorgan
01/30/17
RBCM
01/30/17
NO CHANGE
RBCM
Auto executives say Trump policies to be a 'net positive,' says RBC Capital
RBC Capital analyst Joseph Spak says that auto executives, after speaking with Trump administration officials, predict that the administration's policies will be "net positive" for auto OEMs. Spak says that "pretty much" every company with whom he spoke says that the risk from the policies will be "manageable," The analyst adds that executives who met with administration officials expect " rationality on some of the extreme measures will prevail," while measures such as a reduced corporate tax and less regulation will provide "offsets." Publicly traded companies in the space include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VLKAY).
02/03/17
MACQ
02/03/17
UPGRADE
MACQ
Outperform
Honda upgraded to Outperform from Neutral at Macquarie
08/01/17
NOMU
08/01/17
UPGRADE
NOMU
Neutral
Honda upgraded to Neutral from Reduce at Nomura Instinet
SNE Sony
$39.72

0.09 (0.23%)

04/25/17
04/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sony (SNE) initiated with an Outperform at Bernstein. 2. Rockwell Collins (COL) reinstated with a Sell at Goldman Sachs. 3. Idera Pharmaceuticals (IDRA) initiated with an Outperform at Baird. 4. GasLog (GLOG) initiated with an Outperform at Credit Suisse. 5. Fitbit (FIT) initiated with a Buy at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/21/17
JPMS
04/21/17
UPGRADE
JPMS
Overweight
Sony upgraded to Overweight from Neutral at JPMorgan
04/25/17
BERN
04/25/17
INITIATION
BERN
Outperform
Sony initiated with an Outperform at Bernstein
Bernstein analyst David Dai started coverage of Sony with an Outperform rating. The analyst says that Sony's image sensor business should be boosted by advances in computers' communications capabilities and by the proliferation of VR/AR. The analyst adds that the company's PlayStation console "will maintain the leading position in tethered VR for the next three years at least," and he says that this status "should strengthen the PlayStation ecosystem." ,
06/08/17
BERN
06/08/17
NO CHANGE
BERN
Sony price target raised to $47 from $41 at Bernstein
Bernstein analyst David Dai raised his price target on Sony as he thinks that the company's growth will be boosted by strong sales of its game and image sensors. He keeps an Outperform rating on the stock.
WMT Wal-Mart
$78.37

0.3 (0.38%)

08/25/17
08/25/17
NO CHANGE

Price cuts not a 'silver bullet' for Amazon to disrupt grocery, says Citi
Citi analyst Alvin Concepcion noted that a number of food retail stocks sold off yesterday after Amazon (AMZN) announced price reductions on certain top selling items at Whole Foods (WFM) stores beginning on Monday when their deal closes, but he contends "price cuts alone are not a silver bullet to becoming a disruptive threat" in an industry that already has many discount operators. He adds that he would be wary of a more significant negative overreaction to news around Amazon's price plans at Whole Foods at this time. Some of the food retailing stocks that declined yesterday included Wal-Mart (WMT), Target (TGT), Kroger (KR), Sprouts Farmers Market (SFM), Costco (COST) and Supervalu (SVU).
08/24/17
BARD
08/24/17
NO CHANGE
Target $85
BARD
Outperform
Wal-Mart partnership with Google a 'thoughtful, strategic' move, says Baird
Baird analyst Peter Benedict called the voice-based shopping partnership between Wal-Mart (WMT) and Google (GOOG) both thoughtful and strategic. He believes its demonstrates the value of Wal-Mart's national footprint and its emerging leadership role in the digital commerce world. Benedict reiterated his Outperform rating and $85 price target on Wal-Mart shares.
08/23/17
KEYB
08/23/17
NO CHANGE
KEYB
Wal-Mart, Alphabet deal to increase competition for Amazon, says KeyBanc
KeyBanc says that the partnership deal announced today between Wal-Mart (WMT) and Alphabet (GOOG,GOOGL) will intensify the competition facing Amazon (AMZN). The firm says that the deal will give consumers the capacity to obtain Wal-Mart products through voice ordering. Voice ordering had previously been a competitive advantage of Amazon, according to the firm ,which adds that Wal-Mart's acquisitions and investments have improved its e-commerce offerings.
08/29/17
OPCO
08/29/17
NO CHANGE
OPCO
Whole Foods price cuts deep, not broad yet after Amazon deal, says Oppenheimer
Based on his analysis in New York City following Amazon (AMZN) acquisition, Oppenheimer analyst Rupesh Parikh notes Whole Foods (WFM) cut prices on select items by 22%, or $1.15 on average. The analyst would characterize Whole Foods' cuts as deep, but not broad yet. Parikh expects a heightened period of volatility for grocers to persist given competitive uncertainty, and says he does not expect Wal-Mart (WMT) and Kroger (KR) to let pricing gaps erode. As a result, the analyst would expect counter-reactions if need be to the extent Amazon gets aggressive on a basket of items versus just a few SKUs.
BLK BlackRock
$421.78

2.77 (0.66%)

04/06/17
FBCO
04/06/17
NO CHANGE
Target $530
FBCO
Outperform
BlackRock price target raised to $530 from $464 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for BlackRock to $530 from $464 on valuation. The analyst reiterates an Outperform rating on the shares.
05/25/17
JPMS
05/25/17
NO CHANGE
Target $456
JPMS
Overweight
BlackRock added to Americas Focus List at JPMorgan
JPMorgan analyst Kenneth Worthington raised his price target for BlackRock to $456 from $442 and added the shares to his firm's Americas Focus List. The move reflects a more sanguine view on traditional asset managers, where he sees the potential for better active manager returns from better returns from non-U.S. markets. He maintains an Overweight rating on BlackRock shares.
07/18/17
FBCO
07/18/17
NO CHANGE
Target $534
FBCO
Outperform
BlackRock price target lowered to $534 from $545 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler lowered his price target for BlackRock to $534 from $545 following Q2 results. Nonetheless, the analyst reiterates an Outperform rating on the shares as he forecasts record net flows in 2017, stable-improving base fee organic growth rate and EPS growth of about 15% over the next few years.
04/11/17
MSCO
04/11/17
NO CHANGE
MSCO
Consolidation wave approaching Asset Management industry, says Morgan Stanley
Morgan Stanley analyst Michael Cyprys sees multiple headwinds - including distribution challenges, intensifying fee pressure, new regulation, and a weak organic growth outlook for active management - facing Asset Managers and believes that while M&A may not solve the challenges it can help firms adapt to better navigate the shifting landscape. The analyst, who believes "this time is different," thinks scale can help and predicts a wave of large-scale consolidation is approaching for the industry. Brokers and Asset Managers covered by Morgan Stanley include WisdomTree (WETF), Waddell & Reed (WDR), T. Rowe Price (TROW), Franklin Resources (BEN), Janus Capital (JNS), BlackRock (BLK) and Invesco (IVZ).
NEWR New Relic
$47.98

0.08 (0.17%)

08/17/17
KEYB
08/17/17
NO CHANGE
KEYB
New Relic outlook remains positive despite 'billings controversy,' says KeyBanc
After meeting with New Relic's CFO, KeyBanc analyst Ben McFadden thinks that the recent "'billings controversy" involving the company is "a case of deja vu" and " is largely a function of typical seasonality yet again." The analyst remains confident in the company's outlook and keeps a $52 price target and an Overweight rating on the shares.
07/20/17
MSCO
07/20/17
DOWNGRADE
Target $48
MSCO
Equal Weight
New Relic downgraded to Equal Weight on valuation at Morgan Stanley
As previously reported, Morgan Stanley downgraded New Relic to Equal Weight from Overweight and raised its price target to $48 from $45. Analyst Sanjit Singh said shares are up 71% year-to-date and valuation captures solid fundamentals but sees fewer catalysts.
07/20/17
07/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pfizer (PFE) downgraded to Neutral from Outperform at Credit Suisse with analyst Vamil Divan saying he believes the stock's upside drivers are more limited over the next year. 2. Rite Aid (RAD) downgraded to Neutral from Buy at Mizuho. 3. Fairmount Santrol (FMSA) was downgraded to Sell from Neutral at Goldman Sachs and to Neutral from Outperform at Credit Suisse. 4. New Relic (NEWR) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Sanjit Singh saying shares are up 71% year-to-date and valuation captures solid fundamentals but sees fewer catalysts. 5. Smart Sand (SND) downgraded to Neutral from Outperform at Credit Suisse with analyst James Wicklund saying the regional sand volumes capacity is expanding much faster than had been expected. This drives lower pricing and demand for non-Texas mines, he adds. The analyst also lowered his price target on the shares to $8.50 from $20. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/17
FANA
08/04/17
DOWNGRADE
Target $50
FANA
Equal-Weight
New Relic downgraded to Equal-Weight from Overweight at First Analysis
First Analysis analyst David Vercoutere downgraded New Relic to Equal-Weight from Overweight as he believes the stock is appropriately valued after its 56% year-to-date rally. The analyst, who remains enthusiastic about the company's position in the application and cloud infrastructure monitoring market, keeps a $50 price target on New Relic shares.
ANSS ANSYS
$128.11

-0.71 (-0.55%)

05/04/17
05/04/17
DOWNGRADE
Target $114

Neutral
Update: ANSYS downgraded to Neutral on valuation at MUFG
As previously reported, MUFG downgraded ANSYS to Neutral from Buy. Analyst Stephen Bersey downgraed shares citing limited upside to his new price target of $114, up from $112.
07/17/17
GSCO
07/17/17
INITIATION
Target $112
GSCO
Neutral
ANSYS initiated with a Neutral at Goldman Sachs
Goldman analyst Gabriela Borges initiated ANSYS with a Neutral and a $112 price target saying she would wait for improved earnings driver clarity given expectations for another increase in opex intensity and said it is unclear whether the company will be successful in organically expanding the user base.
08/23/17
BREN
08/23/17
INITIATION
Target $123
BREN
Hold
ANSYS initiated with a Hold at Berenberg
Berenberg analyst Gal Munda initiated ANSYS with a Hold and $123 price target due to valuation.
08/23/17
08/23/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on the today's top five analyst initiations with this list compiled by The Fly: 1. HP Inc (HPQ) initiated with a Buy and HP Enterprise (HPE) initiated with a Hold at Loop Capital. 2. PTC (PTC), Autodesk (ADSK), ASpen Technology (AZPN) and SAP (SAP) initiated with Buy ratings and Trimble (TRMB) and ANSYS (ANSS) initiated with Hold ratings at Berenberg. 3. AveXis (AVXS) initiated with an Outperform at William Blair. 4. LivaNova (LIVN) initiated with a Hold at Needham. 5. Advanced Energy (AEIS) initiated with a Hold at Stifel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FLEX Flex
$16.54

0.27 (1.66%)

05/12/17
CHLM
05/12/17
UPGRADE
CHLM
Buy
Flex upgraded to Buy from Hold at Craig-Hallum
05/12/17
05/12/17
UPGRADE
Target $21.5

Buy
Flex upgraded to Buy at Craig-Hallum
As previously reported, Craig-Hallum analyst Christian Schwab upgraded Flex to Buy from Hold following its Analyst Day where the company outlined a multi-year period of significant earnings growth. The analyst also raised his price target on the shares to $21.50 from $15.
06/22/17
MACQ
06/22/17
INITIATION
Target $18.4
MACQ
Neutral
Flex initiated with a Neutral at Macquarie
Macquarie analyst Gus Papageorgiou initiated Flex (FLEX) with a Neutral and an $18.40 price target saying shares are well above its historic range and expects near-term margin pressure from customer Nike (NKE) near-term.
08/02/17
UBSW
08/02/17
NO CHANGE
Target $18
UBSW
Buy
Flex remains confident Nike relationship can be maintained, says UBS
UBS analyst Steven Milunovich spoke with management of Flex (FLEX), which said their relationship with Nike (NKE) is unique and transparent and both sides are committed to it. The analyst said he likes Flex for its move up the value chain, limited negative exposure to public cloud, and consistent shareholder return. The company believes it can stave off competitive pressures from Asia given its capabilities in high-mix specialized manufacturing, added Milunovich, who reiterated his Buy rating and $18 price target on Flex shares.
PZZA Papa John's
$74.42

-0.37 (-0.49%)

01/20/17
SPHN
01/20/17
INITIATION
Target $180
SPHN
Overweight
Papa John's initiated with an Overweight at Stephens
Stephens analyst Will Slabaugh initiated Papa John's with an Overweight and a $180 price target saying he likes the international opportunity, P&L leverage, and the strong/improving comp environment.
01/03/17
LBOW
01/03/17
NO CHANGE
LBOW
Domino's Pizza, Papa John's are top restaurant long ideas, says Longbow
Longbow analyst Alton Stump identifies Domino's (DPZ) and Papa John's (PZZA) as his top long ideas in the restaurant space. The analyst thinks that both companies could benefit from recent new product launches and will continue to post "impressive" same-store sales "for years to come." He reiterates a $101 price target on Papa John's and a $184 price target on Domino's and keeps Buy ratings on both stocks.
05/22/17
LBOW
05/22/17
NO CHANGE
LBOW
Papa John's Q2 U.S. comp sales exceeding expectations, says Longbow
After speaking with Papa John's franchisees, Longbow analyst Alton Stump estimates that the company's U.S. system-wide comp sales have risen 2.5%-3% so far this quarter, versus the consensus outlook of a 2.2% increase. The analyst says that comp sales were boosted by the company's expanded partnership with MLB and its two medium, two topping pizzas for $6.99 each promotion. Stump is now more confident that the company is recovering from its weaker than expected domestic comp performance in late 2016 and early 2017. He expects it to continue to gain share and keeps a $95 price target and a Buy rating on the stock.
08/28/17
BTIG
08/28/17
NO CHANGE
BTIG
Papa John's outlook has improved, says BTIG
After meeting with PApa John's CFO and COO, BTIG analyst Peter Saleh says he's "optimistic about the company's digital and marketing efforts, the contribution from recent management additions and promotional dynamics within the pizza category." He is "encouraged" by the company's test of a GPS system that he says could reduce delivery drivers' accidents and insurance claims, and notes that the company is developing personalized marketing systems. Saleh says that the latter systems "have considerable potential," and he expects the company to gain market share over the longer term . Saleh keeps a $100 price target and a Buy rating on the shares.
DVA DaVita
$57.88

-0.68 (-1.16%)

06/26/17
06/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GrubHub (GRUB) downgraded to Equal Weight from Overweight by Morgan Stanley analyst John Glass, who lowered his price target to $43 from $47. The firm's survey results indicate 26% of Amazon (AMZN) Prime members have tried Amazon Restaurants in the past 6 months, and other players such as UberEATS and YelpEat24 are emerging, which longer-term will reduce GrubHub's profitability and cash flow, the analyst argues. 2. Stratasys (SSYS) downgraded to Sell from Neutral by Goldman Sachs analyst Matthew Cabral, who noted that the shares are up 67% year-to-date while competition is ramping and price pressure is mounting. 3. DaVita (DVA) downgraded to Hold from Buy by Jefferies analyst Chris Cooper, who cites slowing treatment growth and the "tight" rate environment. 4. Agios Pharmaceuticals (AGIO) downgraded to Neutral by Janney Capital analyst Debjit Chattopadhyay, who believes peak sales estimates for its acute myeloid leukemia treatment are likely to move lower over time. 5. American Electric (AEP) was downgraded to Neutral from Buy while Ameren (AEE) and WEC Energy (WEC) were both downgraded to Sell from Neutral at Goldman Sachs, where analyst Michael Lapides downgraded the Utilities sector to Cautious from Neutral saying valuations now appear stretched while earnings growth appears relatively normal. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/26/17
JEFF
06/26/17
DOWNGRADE
Target $70
JEFF
Hold
DaVita downgraded to Hold from Buy at Jefferies
Jefferies analyst Chris Cooper downgraded DaVita to Hold citing slowing treatment growth and the "tight" rate environment. The analyst believes a less competitive cost base and patient steering allegations are hindering the company's rate negotiations. He sees risk to consensus estimates and keeps a $70 price target for DaVita shares.
12/13/16
12/13/16
DOWNGRADE
Target $69

Neutral
DaVita downgraded to Neutral after CMS guidance at Baird
As previously reported, Baird analyst Whit Mayo downgraded DaVita to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. Mayo, who also cites the stock's 20% bounce off of its bottom and the company's "tepid" organic growth, sees DaVita shares "trading sideways" in the near-term. He raised his price target on DaVita to $69 from $68.
12/13/16
12/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Deutsche Bank analyst Bill Schmitz downgraded Procter & Gamble (PG) to Hold citing a lack of catalysts over the next few quarters. The analyst lowered his price target for P&G shares to $90 from $95 but remains positive on P&G's medium to long-term opportunity. Schmitz also downgraded Coca-Cola (KO) to Hold saying that while CEO James Quincey "is the right person for the turnaround job," near-term stock outperformance will be limited by investor migration out of staples, wellness related consumption headwinds and likely negative earnings revisions. The analyst cut his price target for Coca-Cola shares to $44 from $48. 2. Barclays analyst Karen Short downgraded GNC Holdings (GNC) to Underweight saying the company's recent strategy change and press reports indicating that at least some potential foreign buyers are not interested in the U.S. assets make a potential takeover unlikely. 3. RBC Capital downgraded Viacom (VIAB) to Underperform from Sector Perform after the company announced that it would no longer pursue a merger with CBS (CBS). Wedbush analyst James Dix also downgraded Viacom to Neutral after National Amusements withdrew support for a merger with CBS. 4. Craig-Hallum analyst Chad Bennett downgraded Model N (MODN) to Hold saying the "risks outweigh the benefits" following the company's acquisition of primary competitor Revitas. 5. Baird analyst Whit Mayo downgraded DaVita (DVA) to Neutral from Outperform after CMS issued its notice with respect to third-party premium support for ESRD patients enrolling in Exchange plans, which he views as potentially putting the company's entire $230M HIX tailwind at risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ARA American Renal Associates

06/13/17
RHCO
06/13/17
NO CHANGE
RHCO
American Renal Associates valuation 'compelling,' says SunTrust
SunTrust analyst David MacDonald says that "noise" related to the Affordable Care Act has pressured American Renal's stock. However, he thinks the stock reflects that issue, and he remains upbeat on the dialysis sector. The analyst says that the "noise" has made the stock's valuation "compelling," and he keeps a Buy rating on the shares.
05/11/17
WELS
05/11/17
UPGRADE
Target $22
WELS
Outperform
American Renal Associates upgraded to Outperform at Wells Fargo
Wells Fargo analyst Gary Lieberman upgraded American Renal Associates to Outperform from Market Perform saying most of the negative impact from the reduction in commercial mix is now behind the company. The analyst has a $22 price target for the shares.
03/09/17
03/09/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Casey's General Stores (CASY) downgraded to Neutral from Buy at Northcoast. 2. RE/MAX Holdings (RMAX) downgraded to Sell from Neutral at Compass Point. 3. American Renal Associates (ARA) downgraded to Market Perform at Wells Fargo with analyst Gary Lieberman saying the company's 2017 is uncertain. Management said there could be additional pressure on commercial contracts while the lack of EBITDA guidance is a concern, Lieberman tells investors in a research note. He lowered his price target range for the shares to $17-$19 from $22-$26. 4. Travelport (TVPT) downgraded to Neutral from Buy at UBS with analyst Eric Sheridan saying the company's near-term investments will "place a lid" on the shares. The analyst believes the stock will be "stuck in a trading range" pending greater clarity on forward revenue growth. He cut his price target for the shares to $13 from $18. 5. Virtusa (VRTU) downgraded to Hold from Buy at Maxim with analyst Brian Kinstlinger saying he believes slower industry growth and a need to invest in digital and cloud will cap margin expansion in fiscal 2018 and thinks caution is warranted ahead of the company's fiscal year guidance. He added that he expects the company's FY18 guidance to be "meaningfully" below the current consensus view. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/09/17
WELS
03/09/17
DOWNGRADE
WELS
Market Perform
American Renal Associates downgraded to Market Perform at Wells Fargo
Wells Fargo analyst Gary Lieberman downgraded American Renal Associates to Market Perform from Outperform saying the company's 2017 is uncertain. Management said there could be additional pressure on commercial contracts while the lack of EBITDA guidance is a concern, Lieberman tells investors in a research note. He lowered his price target range for the shares to $17-$19 from $22-$26.

TODAY'S FREE FLY STORIES

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

, ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

20:04
09/24/17
09/24
20:04
09/24/17
20:04
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

ORCL

Oracle

$48.16

0.19 (0.40%)

GPRO

GoPro

$10.75

-0.19 (-1.74%)

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

SIX

Six Flags

$58.96

1.14 (1.97%)

HMC

Honda

$29.91

0.18 (0.61%)

IRBT

iRobot

$76.14

-3.8 (-4.75%)

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 28

    Sep

  • 12

    Oct

  • 24

    Oct

  • 08

    Nov

  • 12

    Jan

NVCR

Novocure

$21.50

-0.1 (-0.46%)

18:27
09/24/17
09/24
18:27
09/24/17
18:27
Hot Stocks
Combination of Novocure Optune with Temozolomide demonstrates five-year survival »

Novocure announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$102.40

-0.09 (-0.09%)

, CMCSA

Comcast

$38.10

0.63 (1.68%)

17:10
09/24/17
09/24
17:10
09/24/17
17:10
Hot Stocks
Box Office Battle: 'Kingsman: The Golden Circle' easily wins weekend »

"Kingsman: The…

TWX

Time Warner

$102.40

-0.09 (-0.09%)

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

SNE

Sony

$37.50

0.04 (0.11%)

FOX

21st Century Fox

$26.43

0.1 (0.38%)

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

LGF.A

Lionsgate

$31.49

0.24 (0.77%)

DIS

Disney

$98.60

-0.29 (-0.29%)

VIAB

Viacom

$27.64

0.24 (0.88%)

VIA

Viacom

$38.00

-0.2 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 29

    Sep

  • 22

    Oct

  • 26

    Oct

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

16:41
09/24/17
09/24
16:41
09/24/17
16:41
Periodicals
Amazon affiliate to buy stake in Indian retailer Shoppers Stop, Reuters says »

An affiliate of Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

16:37
09/24/17
09/24
16:37
09/24/17
16:37
Periodicals
Internet giants on the defensive in Washington, Reuters says »

Internet giants,…

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

, UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

16:25
09/24/17
09/24
16:25
09/24/17
16:25
Periodicals
Opposition to new 'Obamacare' repeal bill grows, Reuters reports »

The new proposal by…

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

CNC

Centene

$92.22

1.48 (1.63%)

WCG

WellCare

$167.16

1.1 (0.66%)

CI

Cigna

$182.74

0.61 (0.33%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

AET

Aetna

$153.57

0.18 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

SAP

SAP

$110.27

0.64 (0.58%)

16:11
09/24/17
09/24
16:11
09/24/17
16:11
Hot Stocks
SAP announces acquisition of Gigya »

SAP has announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATT

TAT Technologies

$10.70

0.05 (0.47%)

, BA

Boeing

$256.45

0.41 (0.16%)

16:03
09/24/17
09/24
16:03
09/24/17
16:03
Hot Stocks
TAT Technologies awarded APU MRO contract for fleet of Boeing, Airbus »

TAT Technologies (TATT),…

TATT

TAT Technologies

$10.70

0.05 (0.47%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.